Literature DB >> 30953181

Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study.

Lu Wang1, Xin Du1,2,3, Jian-Zeng Dong4,5, Wen-Na Liu6, Ying-Chun Zhou6, Song-Nan Li1, Xue-Yuan Guo1, Chen-Xi Jiang1, Rong-Hui Yu1, Cai-Hua Sang1, Ri-Bo Tang1, De-Yong Long1, Nian Liu1, Rong Bai1, Laurent Macle7, Chang-Sheng Ma1.   

Abstract

BACKGROUND: Impact of body mass index (BMI) on all-cause mortality in atrial fibrillation (AF) patients remains controversial.
METHODS: A total of 10,942 AF patients were prospectively enrolled and categorized into four BMI groups: underweight (BMI < 18.5 kg/m2), normal weight (BMI 18.5-24 kg/m2), overweight (BMI 24-28 kg/m2) and obesity (BMI ≥ 28 kg/m2). The primary outcome was all-cause mortality. Different Cox proportional hazards models were performed to evaluate the association between BMI and all-cause mortality.
RESULTS: During a median follow-up of 30 months (IQR 18-48 months), 862 deaths events occurred. Compared to normal BMI, higher BMI was associated with a lower mortality risk (overweight: HR 0.70; 95% CI 0.61-0.81, P < 0.0001 and obesity: HR 0.54; 95% CI 0.44-0.67, P < 0.0001) and lower BMI was associated with a higher mortality risk (HR 2.23, 95% CI 1.67-2.97, P < 0.0001).
CONCLUSION: A reversed relationship between BMI and all-cause mortality in AF patients was found. Higher risk of mortality was observed in underweight patients compared to patients with a normal BMI, while overweight and obese patients had a lower risk of all-cause mortality. CLINICAL TRIAL REGISTRATION: URL: http://www.chictr.org.cn/showproj.aspx?proj=5831. Unique identifier: ChiCTR-OCH-13003729.

Entities:  

Keywords:  All-cause mortality; Arial fibrillation; Body mass index

Mesh:

Year:  2019        PMID: 30953181     DOI: 10.1007/s00392-019-01473-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  41 in total

1.  Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.

Authors:  Alexander Jobs; Julia Schwind; Alexander Katalinic; Valentin Babaev; Roland Richard Tilz; Stefan Rausch; Holger Thiele; Ingo Eitel; Charlotte Eitel
Journal:  Clin Res Cardiol       Date:  2018-07-09       Impact factor: 5.460

2.  Impact of Body Mass Index on the Prognosis of Japanese Patients With Non-Valvular Atrial Fibrillation.

Authors:  Hiroshi Inoue; Eitaro Kodani; Hirotsugu Atarashi; Ken Okumura; Takeshi Yamashita; Hideki Origasa
Journal:  Am J Cardiol       Date:  2016-05-05       Impact factor: 2.778

3.  Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.

Authors:  Juan Wang; Yan-min Yang; Jun Zhu; Han Zhang; Xing-hui Shao; Li Tian; Bi Huang; Li-tian Yu; Xin Gao; Man Wang
Journal:  Clin Res Cardiol       Date:  2014-02-18       Impact factor: 5.460

Review 4.  Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.

Authors:  Carl J Lavie; Ambarish Pandey; Dennis H Lau; Martin A Alpert; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2017-10-17       Impact factor: 24.094

5.  Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.

Authors:  Giuseppe Boriani; Cécile Laroche; Igor Diemberger; Elisa Fantecchi; Joan Meeder; Malgorzata Kurpesa; Monica Mariana Baluta; Marco Proietti; Luigi Tavazzi; Aldo P Maggioni; Gregory Y H Lip
Journal:  J Cardiovasc Electrophysiol       Date:  2018-02-01

6.  The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.

Authors:  Roopinder K Sandhu; Justin Ezekowitz; Ulrika Andersson; John H Alexander; Christopher B Granger; Sigrun Halvorsen; Michael Hanna; Ziad Hijazi; Petr Jansky; Renato D Lopes; Lars Wallentin
Journal:  Eur Heart J       Date:  2016-04-12       Impact factor: 29.983

7.  Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.

Authors:  Annika Rosengren; Paul J Hauptman; Georg Lappas; Lars Olsson; Lars Wilhelmsen; Karl Swedberg
Journal:  Eur Heart J       Date:  2009-03-20       Impact factor: 29.983

8.  Smoking and reverse causation create an obesity paradox in cardiovascular disease.

Authors:  Andrew Stokes; Samuel H Preston
Journal:  Obesity (Silver Spring)       Date:  2015-09-30       Impact factor: 5.002

Review 9.  Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review.

Authors:  Wengen Zhu; Rong Wan; Fuwei Liu; Jinzhu Hu; Lin Huang; Juxiang Li; Kui Hong
Journal:  J Am Heart Assoc       Date:  2016-09-09       Impact factor: 5.501

10.  Rationale and design of the Chinese Atrial Fibrillation Registry Study.

Authors:  Xin Du; Changsheng Ma; Jiahui Wu; Songnan Li; Man Ning; Ribo Tang; Xueyuan Guo; Deyong Long; Ronghui Yu; Caihua Sang; Chenxi Jiang; Ting Zhang; Jianhong Pan; Xiaohui Liu; Jianzeng Dong; Gregory Y H Lip
Journal:  BMC Cardiovasc Disord       Date:  2016-06-07       Impact factor: 2.298

View more
  4 in total

Review 1.  The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox.

Authors:  Maxim Grymonprez; Andreas Capiau; Tine L De Backer; Stephane Steurbaut; Koen Boussery; Lies Lahousse
Journal:  Clin Cardiol       Date:  2021-03-26       Impact factor: 2.882

2.  Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation.

Authors:  Yuji Murakawa; Takanori Ikeda; Satoshi Ogawa; Takanari Kitazono; Jyoji Nakagawara; Kazuo Minematsu; Susumu Miyamoto; Yasuhiro Hayashi; Yoko Kidani; Yutaka Okayama; Toshiyuki Sunaya; Shoichiro Sato; Satoshi Yamanaka
Journal:  Heart Vessels       Date:  2020-04-06       Impact factor: 2.037

3.  Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial.

Authors:  Yansha Song; Xiaocen Wang; Cuicui Chen; Tingting Wei; Ke Lang; Dong Yang; Yuanlin Song
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID-19.

Authors:  Jian Wang; Li Zhu; Longgen Liu; Xiang-An Zhao; Zhaoping Zhang; Leyang Xue; Xuebing Yan; Songping Huang; Yang Li; Juan Cheng; Biao Zhang; Tianmin Xu; Chunyang Li; Fang Ji; Fang Ming; Yun Zhao; Huaping Shao; Dawen Sang; Haiyan Zhao; Xinying Guan; Xiaobing Chen; Yuxin Chen; Rahma Issa; Jie Wei; Rui Huang; Chuanwu Zhu; Chao Wu
Journal:  Obesity (Silver Spring)       Date:  2020-09-23       Impact factor: 9.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.